Continuous NMB in PCAS
Continuous Neuromuscular Blocking Agent for out-of Hospital Cardiac Arrest; Multicenter Randomized Controlled Trial
Sponsor: Asan Medical Center
Listed as NCT02790164, this PHASE2 trial focuses on Out-of-hospital Cardiac Arrest and remains completed. Sponsored by Asan Medical Center, it has been updated 6 times since 2016, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
May 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Asan Medical Center
- Chonnam National University Hospital
- Chun Song Youn
- Hanil General Hospital
- Hanyang University Guri Hospitall
- The Catholic University of Korea
- Uijeongbu St. Mary's Hospital
- Ulsan Universty Hospital
For direct contact, visit the study record on ClinicalTrials.gov .